Elon Musk on Monday threatened Apple with legal action over alleged antitrust violations related…
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against…